HomeTagsHormone-Sensitive

Hormone-Sensitive

Healthcare

U.S. FDA Approves Additional Indication of Darolutamide in Combination With Docetaxel

Globe Newswire - August 8, 2022

Orion’s collaboration partner Bayer announced the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for the oral androgen...

Healthcare

Brand Institute Partners on Brand Name Development for European Commission Approved Treatment

PR Newswire - June 20, 2022

Brand Institute is proud to announce having worked with Myovant Sciences in developing the brand name ORGOVYX, for an oral medication used to treat...